The plots exhibited substantial symmetry (Figures S2325), and the Egger test further supported these findings with p values of 0.707, 0.470, and 0.481, respectively, indicating no significant publication bias for these outcomes
10.1016/j.ijcard.2014.06.045 Int J Cardiol
Statements Data availability statement The original contributions presented in the study are publicly available
While its unclear how many people on these drugs are experiencing vision issues, Norriss attorney, Robert King, said his firm alone has received hundreds of GLP-1 medication and vision-loss related cases
Additional assays commonly measure fatty acid oxidation rates, intracellular lipid accumulation, and downstream signaling intermediates such as cyclic AMP and protein kinase A activation
Treatment trusted by thousands Act before access shifts take the TrimRx quiz today and secure your zepbound weight loss program in Washington